Xylem (NYSE:XYL) Stock Price Target Cut by UBS Group

Xylem (NYSE:XYL) had its price objective cut by UBS Group from $112.00 to $99.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the industrial products company’s stock. UBS Group‘s price objective indicates a potential upside of 9.95% from the stock’s current price.

XYL has been the subject of several other reports. Stifel Nicolaus reduced their price target on Xylem from $141.00 to $114.00 and set a “buy” rating for the company in a report on Wednesday. Oppenheimer dropped their price objective on Xylem from $150.00 to $135.00 and set an “outperform” rating on the stock in a report on Wednesday. Royal Bank Of Canada cut their price objective on Xylem from $135.00 to $125.00 and set an “outperform” rating for the company in a research report on Wednesday. Citigroup reduced their target price on Xylem from $148.00 to $130.00 and set a “buy” rating for the company in a report on Wednesday. Finally, Jefferies Financial Group boosted their target price on shares of Xylem from $145.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, August 24th. Nine equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $121.31.

Xylem Stock Performance

NYSE XYL traded up $1.81 during trading hours on Thursday, hitting $90.04. 2,955,626 shares of the stock were exchanged, compared to its average volume of 2,162,426. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23. The company has a market cap of $21.02 billion, a price-to-earnings ratio of 21.41, a price-to-earnings-growth ratio of 1.75 and a beta of 1.00. Xylem has a 12-month low of $87.40 and a 12-month high of $154.27. The stock has a 50-day moving average of $105.98 and a 200 day moving average of $118.05.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). Xylem had a net margin of 11.15% and a return on equity of 11.77%. The business had revenue of $2.20 billion during the quarter, compared to analysts’ expectations of $2.28 billion. During the same period in the prior year, the firm posted $1.37 EPS. Xylem’s revenue for the quarter was down 3.0% compared to the same quarter last year. As a group, equities research analysts forecast that Xylem will post 5.65 earnings per share for the current year.

Institutional Investors Weigh In On Xylem

Several institutional investors and hedge funds have recently made changes to their positions in XYL. State Street Corp increased its stake in shares of Xylem by 2.4% during the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock worth $1,352,874,000 after purchasing an additional 270,972 shares in the last quarter. Perpetual Ltd raised its position in shares of Xylem by 10.2% during the 3rd quarter. Perpetual Ltd now owns 129,946 shares of the industrial products company’s stock worth $13,160,000 after purchasing an additional 11,993 shares during the last quarter. XXEC Inc. purchased a new stake in Xylem in the 2nd quarter valued at approximately $850,841,000. NFJ Investment Group LLC purchased a new stake in Xylem in the 2nd quarter valued at approximately $4,116,000. Finally, Entropy Technologies LP lifted its stake in Xylem by 45.7% in the 1st quarter. Entropy Technologies LP now owns 36,956 shares of the industrial products company’s stock valued at $4,416,000 after buying an additional 11,583 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Options activity turned notably bullish on Thursday, with traders purchasing 20,508 call contracts—about 771% above average volume. This may indicate speculative expectations for a rebound, although options activity is not necessarily a fundamental signal.
• Positive Sentiment: Royal Bank of Canada initiated coverage with a “moderate buy” rating and a $125 price target. RBC also reaffirmed its positive view, while Citigroup, BNP Paribas Exane, Oppenheimer and Stifel retained buy or outperform ratings despite lowering their targets. Royal Bank of Canada coverage
• Neutral Sentiment: Xylem announced divestitures and a new three-segment structure as part of a portfolio and operational reset. The changes could improve focus and efficiency, but they also introduce execution risk and signal that management is responding to weaker near-term conditions. Xylem announces divestitures and new structure
• Negative Sentiment: Third-quarter revenue was approximately $2.20 billion, below the roughly $2.28 billion consensus estimate, while adjusted EPS also missed expectations. Revenue fell 3% year over year, with soft metering demand and project timing weighing on sales.
• Negative Sentiment: Management lowered its 2026 revenue and earnings outlook and issued weaker fourth-quarter expectations, citing customer pullbacks and continuing near-term headwinds. The guidance reduction was the primary catalyst for the stock’s decline. Xylem cuts outlook and plans restructuring
• Negative Sentiment: Analyst sentiment has become more cautious: JPMorgan downgraded Xylem to neutral and cut its target to $90, while multiple firms reduced targets, including Stifel to $114 and RBC to $125. Elevated put-option activity on Wednesday also reflected bearish positioning.
• Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to shareholder losses, adding legal and headline risk.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.